Skip to main content
$16.14 -$0.42 (-2.5%)

04:00 PM EST on 03/05/21

Amyris Inc Com (NASDAQ:AMRS)

CAPS Rating: 2 out of 5

Current Price $16.14 Mkt Cap $4.0B
Open $16.89 P/E Ratio 0.00
Prev. Close $16.14 Div. (Yield) $0.00 (0.0%)
Daily Range $14.74 - $17.25 Volume 6,789,078
52-Wk Range $1.40 - $22.63 Avg. Daily Vol. 5,423,246

Caps

How do you think NASDAQ:AMRS will perform against the market?

Add Stock to CAPS Watchlist

All Players

98 Outperform
20 Underperform
 

All-Star Players

11 Outperform
5 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:AMRS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

MaxPower13 (97.88)
Submitted March 24, 2014

Just read Maxx's article. http://www.fool.com/investing/general/2014/03/12/can-amyris-inc-save-deep-sea-sharks-and-expand-thi.aspx At this price, I think it's worth taking a shot.

rbitrage (56.83)
Submitted October 14, 2014

No tangible book. No profits in the last year and no earnings in the last year. Currently anything speculative is being punished severely in the market. Expect AMRS to be punished, too.

NASDAQ:AMRS VS S&P 500 (SPY)

NASDAQ:AMRS Summary

Fools bullish on NASDAQ:AMRS are also bullish on:

Fools bearish on NASDAQ:AMRS are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about AMRS.

Recs

0
Member Avatar OmegaProxy (< 20) Submitted: 1/20/2021 4:50:39 AM : Outperform Start Price: $11.55 NASDAQ:AMRS Score: +39.10

Their technology platform (A.I. with fully digitized metabolic pathways of yeast) is now very well developed, Amyris sits at an inflection point in their development. Their new, state-of-the art production facility in Brazil will be completed before the end of this year. Capable of producing around 5 new molecules a year and scaling up the production of these new molecules quickly. Each new molecule capable of disrupting any of a variety of markets. They own multiple brands all in early growth stages. All this combined with the fact that they are largely environmentally friendly and sustainable. Addition of significant talent to their team over the last few years. Oh, and did I forget to mention they got fast-tracked into the Chinese market with Alibaba? John Doerr on the board (You know, the guy Elon Musk wanted on Tesla's board....) There is more, go dig in yourselves.

Recs

0
Member Avatar venturecity (< 20) Submitted: 11/12/2018 1:13:50 AM : Outperform Start Price: $6.29 NASDAQ:AMRS Score: +117.90

key ingredient in stevia zero-calorie sweetener can be produced at large scale by Amyris

Recs

0
Member Avatar DCWD40 (82.55) Submitted: 3/15/2018 5:27:54 PM : Outperform Start Price: $6.74 NASDAQ:AMRS Score: +99.71

Company expecting 60% CAGR through 2022. The company is at break even, has top-tier partners for its products, and will be profitable in 2019.

Leaderboard

Find the members with the highest scoring picks in AMRS.

Score Leader

EgisCodr

EgisCodr (< 20) Score: +557.92

The Score Leader is the player with the highest score across all their picks in AMRS.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
EgisCodr < 20 11/16/2020 Outperform 5Y $2.43 +564.20% +6.27% +557.92 0 Comment
Narbly 76.99 10/2/2020 Outperform 5Y $3.04 +430.92% +15.66% +415.27 0 Comment
tempttempt 75.31 7/17/2019 Outperform 5Y $3.11 +418.97% +27.66% +391.32 0 Comment
debasisp99 55.99 5/29/2020 Outperform 5Y $3.38 +377.51% +27.04% +350.47 0 Comment
mjstocks1234 55.42 8/20/2020 Outperform 5Y $3.50 +361.14% +14.38% +346.76 0 Comment
MSUalum 67.66 11/26/2019 Outperform 5Y $3.85 +319.22% +22.41% +296.82 0 Comment
EclecticRecluse < 20 1/31/2011 Underperform 3W $466.80 -96.54% +199.55% +296.09 1 Comment
SunnySky123 77.94 6/15/2020 Outperform 5Y $3.84 +320.32% +27.96% +292.36 0 Comment
QuantCasting < 20 8/19/2019 Outperform 3M $3.85 +319.22% +31.29% +287.93 0 Comment
SmallCapRoss 21.30 1/17/2012 Underperform 5Y $171.60 -90.59% +194.92% +285.51 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for AMRS.